SCHEMBL6174469

SCHEMBL6174469

CC(c1ccncc1NC(=O)c1ccccc1Cl)C1(C(C)c2ccncc2NC(=O)c2ccccc2Cl)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.42
ALDH1A1 P00352 2/20 0.39
HSD17B13 Q7Z5P4 1/20 0.39
LIPE Q05469 2/20 0.38
GAA P10253 2/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
MAPT P10636 1/20 0.37
GSK3A P49840 1/20 0.37
GSK3B P49841 1/20 0.37
HTT P42858 1/20 0.36
GRM4 Q14833 1/20 0.36
DCTPP1 Q9H773 1/20 0.35
KDM4E B2RXH2 1/20 0.35
EPHX2 P34913 1/20 0.35
NR3C1 P04150 1/20 0.35
CYP11B2 P19099 1/20 0.35
KDR P35968 1/20 0.34
ABL1 P00519 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6174515 0.89 ALDH1A1 (0.45) ALDH1A1HSD17B13GAACYP3A4CYP2C9
SCHEMBL6173454 0.88 CYP2C9 (0.41) ALDH1A1LIPEGAACYP3A4CYP2C9
SCHEMBL6172926 0.88 GAA (0.37) TDP1ALDH1A1HSD17B13GAACYP3A4
SCHEMBL6175217 0.88 GAA (0.42) ALDH1A1HSD17B13LIPEGAACYP3A4
SCHEMBL6172844 0.87 CYP3A4 (0.40) ALDH1A1GAACYP3A4CYP2C9CYP2C19
SCHEMBL6174642 0.86 ALDH1A1 (0.42) ALDH1A1HSD17B13LIPEGAACYP3A4
SCHEMBL6175907 0.85 ALDH1A1 (0.39) ALDH1A1GAACYP3A4CYP2C9CYP2C19
SCHEMBL6172977 0.85 CYP3A4 (0.43) ALDH1A1HSD17B13GAACYP3A4CYP2C9
SCHEMBL6174636 0.84 ALDH1A1 (0.41) ALDH1A1GAACYP3A4CYP2C9CYP2C19
SCHEMBL6278206 0.84 TRPV1 (0.49) ALDH1A1KDM4EEPHX2TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed